MADELINE MUNN: Open Payments
NPI 1174957476 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,460 in 69 payments from 17 companies in 2025. Trend: 2023 $284 · 2024 $0 · 2025 $1,460
Food & beverage: $1,460
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $411 |
| Lilly USA, LLC | 20 | $320 |
| Sequel Med Tech, LLC | 3 | $170 |
| Amgen Inc. | 3 | $79 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| SANOFI-AVENTIS U.S. LLC | 2 | $53 |
| Corcept Therapeutics | 2 | $45 |
| BETA BIONICS, INC. | 2 | $42 |
| Dexcom, Inc. | 2 | $39 |
Products named: Ozempic, JARDIANCE, MOUNJARO, TWIIST, Wegovy, TZIELD, TEPEZZA, RECORLEV.
Industry payments across CT — which companies pay providers there.
